Brucella abortus is a facultative intracellular bacterial pathogen that causes abortion in domestic animals
Brucella abortus is a Gram-negative bacterium which is pathogenic to humans and animals (8) . The establishment of infection depends on an effective entrance of this bacterium through the nasal, oral, and/or conjunctival mucosa. After entering into the host cells, Brucella has the ability to infect and multiply in phagocytic and nonphagocytic cells (10, 15) . However, macrophages are considered the main cells of Brucella residence in the host (3) . The immune response against Brucella infection involves many molecules and cells to trigger a Th1 immune response and activation of CD8 ϩ T cells (12, 26, 27) . Furthermore, gamma interferon (IFN-␥) is essential for host control of Brucella infection (24, 32, 41) .
The innate immune response against Brucella abortus infection begins with the recognition of molecular structures related to this pathogen by receptors such as Toll-like receptors (TLRs) (28) . TLRs are transmembrane receptors that recognize pathogen-associated molecular patterns (PAMPs) and lead to the expression of proinflammatory cytokine-related genes (2, 36) . Upon activation, TLRs associate with the myeloid differentiation factor 88 (MyD88), an adaptor molecule of all TLRs, except TLR3, recruiting interleukin-1 (IL-1) receptor-associated kinase (IRAK) proteins and tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6), subsequently (1) . Once interacted with MyD88, IRAK is activated by phosphorylation dependent on TAK1 (transforming growth factor-␤-activated kinase) and then associates with TRAF6, leading to the activation of two distinct signaling pathways, and finally to the activation of JNK (Janus kinase) and nuclear factor B (NF-B) signaling pathways (1) . Activated TAK1 phosphorylates IKK-␤ (IB kinase) and mitogen-activated protein kinase (MAPK) kinase 6 (MKK6), culminating in the degradation of IB, leaving the NF-B to be translocated to the nucleus and to activate the transcription of multiple genes of proinflammatory cytokines such as IL-12 and TNF-␣ (29) . Four members of the IRAK protein family have been identified so far: IRAK-1, IRAK-2, IRAK-3 (also known as IRAK-M), and IRAK-4 (5, 25, 40, 19) . Among the members of this protein family, IRAK-4 and IRAK-1 are recruited to the TLR receptor complex through interaction with MyD88 (14, 20) . However, only the involvement of IRAK-4 in the signal transduction pathway dependent on MyD88 has been demonstrated to be essential for the signaling mediated by the IL-1 receptor and TLRs (33) . Furthermore, the response via the IL-18 receptor is also dependent on IRAK-4 (34) .
Brucella infection induces an inflammatory response through the expression of several genes involved in inflammation (31) . Some in vitro and in vivo studies have shown the involvement of TLR2, TLR4, and TLR9 in the recognition of Brucella and the induction of inflammatory response (4, 11, 13, 22, 39) . Moreover, our group and others have demonstrated that MyD88 is essential for host control of Brucella infection in vivo and the induction of proinflammatory cytokines (7, 22, 39) . Taking into account the critical role of MyD88 during Brucella infection, we decided to study the role of IRAK-4 by using knockout (KO) mice. In this study, we observed that the initial control of Brucella infection in vivo is IRAK-4 dependent. However, differently from MyD88 KO mice, animals deficient in IRAK-4 are as resistant as heterozygous control mice (IRAK-4 ϩ/Ϫ ) at later stages of Brucella infection. Furthermore, IRAK-4 plays a crucial role in Brucella-induced IL-12 and TNF-␣ production by macrophages and dendritic cells (DCs) in vitro. Finally, to determine the role of IRAK-4-mediated signaling in macrophage activation by Brucella, we analyzed the phosphorylation of extracellular signal-regulated kinase 1 (ERK1), ERK2, and p38 as well as p65 NF-B. The results obtained here indicated that IRAK-4 and MyD88 are required for cell signaling induced by Brucella activation of macrophages.
This is the first report demonstrating the role of IRAK-4 in vivo during an intracellular Gram-negative bacterial infection. In summary, IRAK-4 signaling during Brucella infection corroborates with the importance of TLR-MyD88 effective response involved in this disease.
MATERIALS AND METHODS

Mice. IRAK-4 genetically deficient mice (IRAK-4 Ϫ/Ϫ
) and IRAK-4-heterozygous animals (IRAK-4 ϩ/Ϫ ) were gifted by Alan Sher (NIH, Bethesda, MD) and Andre Bafica (UFSC, Brazil). MyD88 genetically deficient mice (MyD88 Ϫ/Ϫ ) were provided by S. Akira (Osaka University, Osaka, Japan). The wild-type strain C57BL/6 mice were purchased from the Federal University of Minas Gerais (UFMG, Belo Horizonte, Brazil). The animals were maintained at UFMG and used at 6 to 8 weeks of age.
Bacteria. Brucella abortus strain S2308 was obtained from our laboratory collection (38) . Strain S2308 was grown in Brucella broth (BB) liquid medium (Difco) at 37°C under constant agitation. After 3 days of growth, the bacterial culture was centrifuged and the pellet was resuspended in 0.15 M phosphatebuffered saline (PBS), pH 7.4 (2.8 mM Na 2 PO 4 , 7.2 mM Na 2 HPO 4 , 0.14 M NaCl). Aliquots of these cultures were serially diluted and plated on BB medium containing 1.5% bacteriological agar. After incubation for 72 h at 37°C, bacterial numbers were determined by counting CFU.
B. abortus infection. Five mice from each group (IRAK-4 Ϫ/Ϫ and IRAK-4 ϩ/Ϫ ) were infected intraperitoneally with 1 ϫ 10 6 CFU of B. abortus virulent strain S2308. These mice were sacrificed at 1, 3, and 6 weeks after infection. The spleen harvested from each animal was macerated in 10 ml of saline (NaCl 0.8%) and used for counting of CFU and splenocyte culturing. For CFU determination, spleen cells were serially diluted and were plated in duplicate on BB agar. After 3 days of incubation at 37°C, the number of CFU was determined. Results were expressed as the mean log CFU of each group. The results are representative of three independent experiments. Blood samples were collected from IRAK-4
and IRAK-4 ϩ/Ϫ mice at 1, 3, and 6 weeks postinfection to determine IL-12 and IFN-␥ levels by enzyme-linked immunosorbent assay (ELISA) using the Duoset kit (R&D Systems, Minneapolis, MN) according to the manufacturer's instructions.
Measurement of IFN-␥ into splenocyte culture supernatants. Spleen cells from IRAK-4 Ϫ/Ϫ and IRAK-4 ϩ/Ϫ mice were treated with ACK buffer (0.15 M NH 4 Cl, 1.0 mM KHCO 3 , 0.1 mM Na 2 EDTA, pH 7.2) to lyse red blood cells. After that, the cells were washed with saline (NaCl, 0.8%) and suspended in RPMI 1640 (Gibco, Carlsbad, CA) supplemented with 2 mM L-glutamine, 25 mM HEPES, 10% heat-inactivated fetal bovine serum (FBS; Gibco, Carlsbad, CA), penicillin G sodium (100 U/ml), and streptomycin sulfate (100 g/ml). To determine cytokine concentration by ELISA, 1 ϫ 10 6 spleen cells were plated per well in a 96-well tissue culture-treated dish. Splenocytes were stimulated with B. abortus S2308 (multiplicity of infection [MOI] , 100:1), heat-killed B. abortus (HKBa; MOI, 100:1), Pam3CSK4 (1 g/ml; InvivoGen, San Diego, CA), CpG ODN1826 (1 g/ml; InvivoGen), or concanavalin A (5 g/ml; Sigma-Aldrich, St. Louis, MO). Unstimulated cells were used as the negative control. Spleen cells were incubated at 37°C in 5% CO 2 for 72 h, after which supernatants were harvested for measuring IFN-␥ levels. IFN-␥ was measured into cell supernatants by ELISA using the Duoset kit (R&D Systems, Minneapolis, MN) according to the manufacturer's instructions.
Flow cytometry analysis. To determine the percentage of CD4
ϩ or CD8 ϩ T cells producing IFN-␥ in IRAK-4 Ϫ/Ϫ compared to IRAK-4 ϩ/Ϫ mice, flow cytometry analysis was performed and 1 ϫ 10 6 spleen cells were plated per well in a 96-well tissue culture-treated dish. Cells were stimulated with HKBa (MOI, 100:1) or concanavalin A (5 g/ml; Sigma). Spleen cells were incubated overnight at 37°C in 5% CO 2 for 40 h, after which 1 g/well of brefeldin A (SigmaAldrich) was added and the cells were incubated for an additional 4 h. Then, cells were incubated with FcBlock anti-mouse CD16/32 (clone 93; eBiosciences, San Diego, CA) in fluorescence-activated cell sorter (FACS) buffer (0.15 M PBS, 0.25% bovine serum albumin [BSA], 1 mM NaN 3 ) for 20 min and were stained for surface markers at 4°C for 20 min with the appropriate monoclonal antibodies: fluorescein isothiocyanate (FITC)-conjugated anti-mouse-CD4 (clone GK1.5; eBiosciences, San Diego, CA) or Cy5-conjugated anti-mouse-CD8 (clone 53-6.7; eBiosciences, San Diego, CA). The cells were washed with PBS-BSA and fixed with 4% formaldehyde for 30 min. After that, cells were permeabilized with a 0.5% saponin solution in PBS and stained for intracellular IFN-␥ with phycoerythrin (PE)-conjugated anti-mouse-IFN-␥ (clone XMG1.2; BD Pharmingen, San Diego, CA). Finally, samples were washed as mentioned before and resuspended in PBS-BSA. Flow cytometry analysis was performed using a FACSCalibur instrument (Becton Dickinson, San Diego, CA); 70,000 events were collected and the data were analyzed considering the percentage of IFN-␥-producing cells within the CD4 ϩ or CD8 ϩ T-lymphocyte population by using FlowJo software (Tree Star, Ashland, OR).
Generation and in vitro stimulation of BMDMs and BMDCs. Macrophages were derived from bone marrow (BM) of C57BL/6, MyD88
Ϫ/Ϫ , IRAK-4 ϩ/Ϫ , and IRAK-4 Ϫ/Ϫ mice as previously described (6) . Briefly, BM cells were removed from the femurs and tibias of the animals and cultured in Dulbecco's modified Eagle medium (DMEM; Gibco, Carlsbad, CA) containing 10% FBS (HyClone, Logan, UT), 1% HEPES, and 10% L929 cell-conditioned medium (LCCM) as the source of macrophage colony-stimulating factor (M-CSF) in 24-well plates (5 ϫ 10 5 cells/well). After 4 days, 100 l/well of LCCM was added. At day 7, the medium was renewed. At day 10 of culture, when the cells had completely differentiated into macrophages, the medium was harvested, and we added supplemented DMEM (500 l/well) containing B. abortus S2308 (MOI, 1,000:1), HKBa (MOI, 1,000:1), Pam3CSK4 (1 g/ml; InvivoGen, San Diego, CA), CpG ODN1826 (1 g/ml, InvivoGen), Brucella L-Omp19 lipoprotein (5 g/ml; gift of Guillermo Giambartolomei), Brucella DNA (1 g/ml), or Escherichia coli lipopolysaccharide (LPS) (1 g/ml; Sigma, St. Louis, MO). DCs were derived from the femurs and the tibias of IRAK-4 ϩ/Ϫ and IRAK-4 Ϫ/Ϫ mice according to the work of Macedo et al. (22) . Briefly, BM cells were cultured in DMEM (Gibco, Carlsbad, CA) containing 10% FBS (HyClone, Logan, UT), 100 U/ml of penicillin, and 100 g/ml of streptomycin plus 20 ng/ml of murine recombinant granulocyte-monocyte colony-stimulating factor (rGM-CSF). Petri dishes containing 1 ϫ 10 7 cells were incubated at 37°C, under an atmosphere of 5% CO 2 . At day 3 of incubation, a further 5 ml of fresh complete medium containing GM-CSF was added, and on days 6 and 8, 3 ml of medium was removed from the culture and replaced with fresh supplemented medium containing GM-CSF. At day 10, nonadherent cells were harvested and seeded in round-bottom 96-well culture plates (3 ϫ 10 5 cells/well). Stimulation of the BM dendritic cells (BMDCs) followed the same protocol described above for the bone marrowderived macrophages (BMDMs), but the stimuli were added in 200 l of DMEM/well. Culture supernatants of BMDMs and BMDCs were collected after 24 h of stimulation and assayed for the concentrations of IL-12 and TNF-␣ by ELISA (R&D Systems) according to the manufacturer's instructions.
Western blot analysis. For Western blot analysis, BMDMs of C57BL/6, MyD88
, and IRAK-4 Ϫ/Ϫ mice were used. BMDMs were differentiated in 6-well plates (2 ϫ 10 6 cells/well). At day 10 of culture, the medium was harvested, DMEM was added, and the cells were maintained for 12 h. After 12 h, the medium was harvested and DMEM (1 ml/well) containing B. abortus S2308 (MOI, 1,000:1) or E. coli LPS (1 g/ml; Sigma, St. Louis, MO) as the control was added to the culture. After 0, 10, 30, or 60 min of stimulation, BMDMs were lysed with a cytoplasmic lysis buffer (50 mM Tris-HCl [pH 7.4],phospho-p38 (Thr180/Tyr182), anti-phospho-NF-B (p65, Ser536), and anti-␤-actin (13E5) were purchased from Cell Signaling Technology Inc. (Danvers, MA). Immunoreactive bands were visualized using Luminol chemiluminescent horseradish peroxidase (HRP) substrate (Millipore) and analyzed in Storm System 860 (Amersham Biosciences). The analyses of densitometry were performed using software KODAK version 1D-3.5.
Statistical analysis. The results of this study were analyzed using Student's t test with GraphPad Prism 4 (GraphPad Software, Inc). The level of significance in the analysis was P Ͻ 0.05. (Fig. 3A) . At 3 weeks postinfection, the levels of IFN-␥ produced by IRAK-4 ϩ/Ϫ and by IRAK-4 Ϫ/Ϫ mice were still significantly different, even though this difference was less pronounced (Fig. 3B) . However, at 6 weeks postinfection the levels of IFN-␥ produced by IRAK-4 Ϫ/Ϫ cells were similar to those seen for IRAK-4 ϩ/Ϫ cells (Fig. 3C ). This result parallels the difference in bacterial burdens observed at 1 week postinfection in IRAK-4 Ϫ/Ϫ mice and IRAK-4 ϩ/Ϫ animals. Taken together, these results suggest that the lack of IRAK-4 causes a severe defect in the induction of type 1 immune response by B. abortus during the initial phases of infection.
RESULTS
IRAK-4
Lack of IRAK-4 causes a significant reduction in proinflammatory cytokine production by macrophages and dendritic cells. The recognition of Brucella by innate immune cells, such as macrophages and dendritic cells, results in activation and the concomitant production of proinflammatory cytokines (22) . In order to evaluate the role of IRAK-4 in proinflammatory cytokine production, macrophages and dendritic cells de- Ϫ/Ϫ and IRAK-4 ϩ/Ϫ mice were infected, and the numbers of bacteria in the spleens were analyzed by counting CFU at 1, 3, and 6 weeks after infection. Data are expressed as mean Ϯ standard deviation (SD) for five animals per time point. These results are representative of three independent experiments. A significant difference in relation to IRAK-4 ϩ/Ϫ is denoted by an asterisk (P Ͻ 0.05).
FIG. 2. Serum IL-12 and IFN-␥ levels after B. abortus infection. IRAK-4
Ϫ/Ϫ and IRAK-4 ϩ/Ϫ mice were infected and blood samples were collected at 1, 3, and 6 weeks postinfection. IL-12 (A) and IFN-␥ (B) levels were measured by ELISA. A significant difference in relation to IRAK-4 ϩ/Ϫ is denoted by an asterisk (P Ͻ 0.05).
As shown in Fig. 4 , a severe deficiency in IL-12 ( Fig. 4A ) and TNF-␣ ( (Fig. 6B) . Regarding E. coli LPS, we observed a delayed kinetics in p38 and p65 NF-B phosphorylation in IRAK-4 Ϫ/Ϫ and MyD88 Ϫ/Ϫ macrophages; this result suggests that the TLR4-mediated TRIF-dependent pathway is intact in these cells (9) . Collectively, these results suggest that Brucella-mediated activation of MAPK and NF-B pathways is mainly IRAK-4 and MyD88 dependent.
DISCUSSION
The involvement of TLRs in the recognition of Brucella has been shown previously by several investigators (4, 11, 22, 39) . The recognition of pathogens by TLRs leads to an immune response that culminates in the production of the proinflammatory cytokines, amplification of the innate immune response, and activation of the adaptive immune system (2). Furthermore, IL-12 and IFN-␥ are directly related to control of infection with B. abortus (24, 32, 41) . In this context, a better understanding of how TLR signaling events are initiated and how they are transduced within the cell provides important information to help decipher the puzzle of host-Brucella relationship.
The first study showing the involvement of TLRs in resistance to B. abortus used mice deficient for the adaptor molecule MyD88 (13) . MyD88 Ϫ/Ϫ mice were unable to induce IL-12 and TNF-␣ when stimulated with heat-killed Brucella abortus (HKBa). Further studies about the role of MyD88 in Brucella response in vivo revealed the exacerbation of murine brucellosis in mice deficient for this adaptor molecule (7, 22, 39) . Herein, we have demonstrated that IRAK-4 is necessary nists (23, 30) . Although these patients have a strong impairment in TLR signaling, IRAK-4-deficient subjects become resistant to bacterial infections with age, and it is likely that adaptive immunity plays a crucial role in the control of these pathogens (18) . In order to determine which factors could be involved with enhanced susceptibility to initial Brucella infection in IRAK- Ϫ/Ϫ mice is severely impaired. In our study, we speculate that reduced IFN-␥ production by Brucella-primed CD4 ϩ and CD8 ϩ T lymphocytes from IRAK-4 Ϫ/Ϫ mice is probably due to the reduced production of IL-12 by macrophages and dendritic cells rather than a defect in TCR signaling, since these T cells recovered the ability to produce IFN-␥ at later stages of infection at levels similar to those seen for IRAK-4 ϩ/Ϫ animals. Macrophages and DCs are key elements in innate immune responses, and recognition of Brucella components results in the production of proinflammatory cytokines by these cells (22) . Herein, we investigated the involvement of IRAK-4 in Brucella-induced IL-12 and TNF-␣ production by macrophages and DCs. Macrophages and DCs deficient in IRAK-4 showed a blockage in the production of TNF-␣ and IL-12 not only when they were stimulated with live Brucella and HKBa but also when they were stimulated by TLR2 and TLR9 agonists. Additionally, our results revealed that Brucella L-Omp19 lipoprotein and Brucella DNA are important bacterial PAMPs responsible for TLR activation leading to IRAK-4 signaling. This demonstrates that IRAK-4 is a critical component involved in the production of these cytokines as result of Brucella recognition by innate immune cells and corroborates the idea of the importance of this kinase in the TLR signaling pathway. Suzuki et al. (33) also found that macrophages deficient in IRAK-4 were unable to produce inflammatory mediators in response to treatment with TLR2 agonist (peptidoglycan). Interestingly, when LPS (TLR4 agonist) was used as the stimulus, we observed partial production of IL-12 and TNF-␣ by DCs and TNF-␣ by macrophages. This observation is due to the fact that TLR4 uses an alternative signaling pathway for cytokine production that is TRIF dependent and MyD88 independent (9) .
TLRs signal through IRAK-4 to mediate many cellular responses, including proinflammatory cytokine production (33) . To investigate whether Brucella requires IRAK-4 to mediate intracellular signaling, we examined the phosphorylation of MAPKs (ERK1, ERK2, and p38) and the p65 subunit of NF-B. Herein, we observed that Brucella-mediated activation of MAPK and NF-B pathways in macrophages is IRAK-4 and MyD88 dependent. Thus, the lack of Brucella-induced signaling in macrophages may account for the low cytokine production observed in IRAK-4 Ϫ/Ϫ mouse macrophages. In contrast, LPS-induced MAPK and NF-B activation seems to be only partially regulated by IRAK-4 and MyD88 molecules (9) .
Collectively, we have demonstrated that IRAK-4 is important in in vivo control of Brucella at early stages of infection and that the lack of this molecule impaired IFN-␥ production by CD4 ϩ and CD8 ϩ T cells. Furthermore, IRAK-4 deficiency resulted in no activation of MAPK and NF-B signaling pathways affecting IL-12 and TNF-␣ production by macrophages and dendritic cells. However, the mechanisms by which IRAK-4 Ϫ/Ϫ mice reestablish a normal IFN-␥ response and control later phases of Brucella infection remain to be explored.
